Dafne Capelusnik
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Corrigendum to "Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI)" [Seminars in Arthritis and Rheumatism 78 (2026) 152981].
Journal: Seminars in arthritis and rheumatism
Published: June 06, 2026
The influence of symptom duration on flare risk after biologic DMARD withdrawal in axial spondyloarthritis: a meta-analysis of randomized withdrawal trials.
Journal: Joint bone spine
Published: April 20, 2026
Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project.
Journal: Annals of the rheumatic diseases
Published: March 30, 2026
Measurement properties of instruments assessing peripheral arthritis disease activity in spondyloarthritis: a systematic literature review.
Journal: RMD open
Published: March 03, 2026
Development and validation analysis of a corrected axial spondyloarthritis metrology index (CASMI).
Journal: Seminars in arthritis and rheumatism
Published: December 19, 2025
Coping with rheumatic stressors in long-standing axial spondyloarthritis: association with patient and disease characteristics.
Journal: Rheumatology (Oxford, England)
Published: November 24, 2025
Peripheral manifestations in spondyloarthritis: a systematic literature review on their assessment and the effect of biological/targeted synthetic DMARDs.
Journal: Rheumatology (Oxford, England)
Published: September 29, 2025
The likelihood of joint inflammation recurrence in previously affected joints during psoriatic arthritis disease course.
Journal: Annals of the rheumatic diseases
Published: June 14, 2025
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 13, 2025
Does symptom duration impact on treatment response in axial spondyloarthritis? A meta-analysis of randomized controlled trials.
Journal: Rheumatology (Oxford, England)
Published: March 22, 2025
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44).
Journal: Annals of the rheumatic diseases
Published: March 14, 2025
Last Updated: 09/26/2026